564 related articles for article (PubMed ID: 31727112)
1. NG2 glia regulate brain innate immunity via TGF-β2/TGFBR2 axis.
Zhang SZ; Wang QQ; Yang QQ; Gu HY; Yin YQ; Li YD; Hou JC; Chen R; Sun QQ; Sun YF; Hu G; Zhou JW
BMC Med; 2019 Nov; 17(1):204. PubMed ID: 31727112
[TBL] [Abstract][Full Text] [Related]
2. NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.
Javed H; Thangavel R; Selvakumar GP; Dubova I; Schwartz N; Ahmed ME; Zaheer S; Kempuraj D; Iyer S; Zaheer A; Khan MM
Int Immunopharmacol; 2020 Jun; 83():106441. PubMed ID: 32259702
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
4. NG2 glia are required for maintaining microglia homeostatic state.
Liu Y; Aguzzi A
Glia; 2020 Feb; 68(2):345-355. PubMed ID: 31518022
[TBL] [Abstract][Full Text] [Related]
5. Diphtheria toxin induced but not CSF1R inhibitor mediated microglia ablation model leads to the loss of CSF/ventricular spaces in vivo that is independent of cytokine upregulation.
Bedolla A; Taranov A; Luo F; Wang J; Turcato F; Fugate EM; Greig NH; Lindquist DM; Crone SA; Goto J; Luo Y
J Neuroinflammation; 2022 Jan; 19(1):3. PubMed ID: 34983562
[TBL] [Abstract][Full Text] [Related]
6. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
[TBL] [Abstract][Full Text] [Related]
7. Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson's Disease.
Kempuraj D; Selvakumar GP; Zaheer S; Thangavel R; Ahmed ME; Raikwar S; Govindarajan R; Iyer S; Zaheer A
J Neuroimmune Pharmacol; 2018 Mar; 13(1):100-112. PubMed ID: 28952015
[TBL] [Abstract][Full Text] [Related]
8. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
9. 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.
Zhang W; Qin L; Wang T; Wei SJ; Gao HM; Liu J; Wilson B; Liu B; Zhang W; Kim HC; Hong JS
FASEB J; 2005 Mar; 19(3):395-7. PubMed ID: 15596482
[TBL] [Abstract][Full Text] [Related]
10. The activation of NG2 expressing cells is downstream to microglial reaction and mediated by the transforming growth factor beta 1.
Xiang P; Zhu L; Jiang H; He BP
J Neuroimmunol; 2015 Feb; 279():50-63. PubMed ID: 25670001
[TBL] [Abstract][Full Text] [Related]
11. MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice.
Costa G; Frau L; Wardas J; Pinna A; Plumitallo A; Morelli M
Mov Disord; 2013 Dec; 28(14):1957-65. PubMed ID: 24108425
[TBL] [Abstract][Full Text] [Related]
12. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.
Gao HM; Jiang J; Wilson B; Zhang W; Hong JS; Liu B
J Neurochem; 2002 Jun; 81(6):1285-97. PubMed ID: 12068076
[TBL] [Abstract][Full Text] [Related]
13. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
Morale MC; Serra PA; L'episcopo F; Tirolo C; Caniglia S; Testa N; Gennuso F; Giaquinta G; Rocchitta G; Desole MS; Miele E; Marchetti B
Neuroscience; 2006; 138(3):869-78. PubMed ID: 16337092
[TBL] [Abstract][Full Text] [Related]
14. Brain Transforming Growth Factor-β Resists Hypertension Via Regulating Microglial Activation.
Li Y; Shen XZ; Li L; Zhao TV; Bernstein KE; Johnson AK; Lyden P; Fang J; Shi P
Stroke; 2017 Sep; 48(9):2557-2564. PubMed ID: 28698257
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions.
Marchetti B; Serra PA; Tirolo C; L'episcopo F; Caniglia S; Gennuso F; Testa N; Miele E; Desole S; Barden N; Morale MC
Brain Res Brain Res Rev; 2005 Apr; 48(2):302-21. PubMed ID: 15850669
[TBL] [Abstract][Full Text] [Related]
16. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes.
Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS
J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442
[TBL] [Abstract][Full Text] [Related]
17. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
Choi DY; Lee MK; Hong JT
Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
[TBL] [Abstract][Full Text] [Related]
18. GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment.
Mendes-Oliveira J; Lopes Campos F; Videira RA; Baltazar G
Brain Behav Immun; 2017 Aug; 64():296-307. PubMed ID: 28450223
[TBL] [Abstract][Full Text] [Related]
19. LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1 -mediated signalling pathways.
Ma B; Xu L; Pan X; Sun L; Ding J; Xie C; Koliatsos VE; Cai H
Hum Mol Genet; 2016 Aug; 25(16):3515-3523. PubMed ID: 27378696
[TBL] [Abstract][Full Text] [Related]
20. Dual modulation on glial cells by tetrahydroxystilbene glucoside protects against dopamine neuronal loss.
Zhou Y; Wang G; Li D; Wang Y; Wu Q; Shi J; Zhang F
J Neuroinflammation; 2018 May; 15(1):161. PubMed ID: 29801454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
